Mettler Toledo International (MTD) Net Income towards Common Stockholders (2009 - 2026)
Mettler Toledo International (MTD) posted quarterly Net Income towards Common Stockholders of $232.9 million for Q2 2026, up 15.1% year-over-year from $202.3 million in Q2 2025, and up 37.44% on a QoQ basis from $169.5 million in Q1 2026.
Mettler Toledo International (MTD) Net Income towards Common Stockholders (2009 - 2026) Analysis & Trends
Mettler Toledo International has reported Net Income towards Common Stockholders for 18 years, with the latest figure at $232.9 million in Q2 2026.
- Net Income towards Common Stockholders for Q2 2026 came in at $232.9 million, up 15.1% year-over-year; the trailing twelve-month figure through Jun 2026 was $905.6 million (up 9.14% YoY), and the FY2025 annual result was $869.2 million, up 0.7% from the prior year.
- Net Income towards Common Stockholders rose to $232.9 million in Q2 2026, from $169.5 million in the prior quarter.
- Over five years, Net Income towards Common Stockholders peaked at $285.8 million in Q4 2025 and troughed at $163.6 million in Q1 2025.
- A 5-year average of $210.9 million and a median of $211.8 million in 2022 frame the typical range for Net Income towards Common Stockholders.
- The widest annual swing landed in 2023, when Net Income towards Common Stockholders sank 30.49%; it then jumped 36.53% in 2024.
- A 5-year view of Net Income towards Common Stockholders shows it stood at $265.8 million in 2022, then slumped by 30.49% to $184.8 million in 2023, then jumped by 36.53% to $252.3 million in 2024, then grew by 13.26% to $285.8 million in 2025, then slipped by 18.5% to $232.9 million in 2026.
- Per Business Quant data, the three most recent Net Income towards Common Stockholders figures were $232.9 million in Q2 2026, $169.5 million in Q1 2026, and $285.8 million in Q4 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 213.86 Bn | 209.80 Bn | 8.34 Bn | 1.76 Bn |
| 2 | Danaher | 140.41 Bn | 136.07 Bn | 3.61 Bn | 870.00 Mn |
| 3 | Idexx Laboratories | 46.33 Bn | 46.13 Bn | 779.09 Mn | 338.41 Mn |
| 4 | Agilent Technologies | 39.71 Bn | 37.90 Bn | 990.00 Mn | 339.00 Mn |
| 5 | Iqvia Holdings | 39.35 Bn | 37.27 Bn | 1.44 Bn | 241.00 Mn |
| 6 | Natera | 38.97 Bn | 37.87 Bn | 696.04 Mn | -85.11 Mn |
| 7 | Illumina | 30.09 Bn | 28.92 Bn | 770.00 Mn | 207.00 Mn |
| 8 | Mettler Toledo International | 28.70 Bn | 28.65 Bn | 650.22 Mn | 232.90 Mn |
| 9 | Quest Diagnostics | 26.19 Bn | 25.56 Bn | 1.03 Bn | 324.00 Mn |
| 10 | Labcorp Holdings | 25.89 Bn | 24.91 Bn | 1.01 Bn | 278.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 232.90 Mn |
| Mar 31, 2026 | 169.45 Mn |
| Dec 31, 2025 | 285.77 Mn |
| Sep 30, 2025 | 217.49 Mn |
| Jun 30, 2025 | 202.35 Mn |
| Mar 31, 2025 | 163.59 Mn |
| Dec 31, 2024 | 252.30 Mn |
| Sep 30, 2024 | 211.52 Mn |
| Jun 30, 2024 | 221.81 Mn |
| Mar 31, 2024 | 177.51 Mn |
| Dec 31, 2023 | 184.79 Mn |
| Sep 30, 2023 | 201.63 Mn |
| Jun 30, 2023 | 213.93 Mn |
| Mar 31, 2023 | 188.43 Mn |
| Dec 31, 2022 | 265.83 Mn |
| Sep 30, 2022 | 220.60 Mn |
| Jun 30, 2022 | 212.07 Mn |
| Mar 31, 2022 | 174.00 Mn |
| Dec 31, 2021 | 230.87 Mn |
| Sep 30, 2021 | 203.69 Mn |